NEW YORK – Researchers from the Trans-Omics for Precision Medicine (TOPMed) program have detected hundreds of millions of variants, many of them novel, in the genomes of more than 50,000 individuals, creating a resource to help elucidate the genetic architecture of heart, lung, blood, and sleep disorders in order to improve diagnosis, treatment, and prevention.